Paul Thomas
Known title: DirectorCIK: 0001166776
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Craig-Hallum initiates coverage on TELA Bio with $2 target. Craig-Hallum has started tracking TELA Bio, assigning a price target of $2. This new analyst note aligns with the current average analyst target of $2.08. The stock is currently trading above its 52-week low of $0.50, with recent technical indicators showing momentum near the upper end of its recent range.
Transaction History
| AXGN | ▲ Buy | Option Exercise | 18,867 | $0 | 6/19/2026 | View on chart |
| TELA | ▲ Buy | Grant | 11,925 | $0 | 6/9/2026 | View on chart |
| TELA | ▲ Buy | Grant | 11,675 | $0 | 6/9/2026 | View on chart |
| AXGN | ▼ Sell | Open Market | 21,399 | $634K | 12/9/2025 | View on chart |
| AXGN | ▲ Buy | Grant | 2,875 | — | 9/16/2024 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 11,904 | $0 | 9/1/2024 | View on chart |
| AXGN | ▲ Buy | Grant | 10,653 | — | 6/6/2024 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 6,459 | $0 | 6/1/2023 | View on chart |
| AXGN | ▲ Buy | Grant | 3,036 | $0 | 6/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Axogen Receives New Analyst Coverage and Valuation Upside
Axogen has attracted new analyst coverage from Robinhood and B of A Securities, both issuing bullish notes and setting price targets around $52. A Yahoo analysis suggests the stock may be about 26% undervalued on cash‑flow grounds, while the company has fallen 22.6% in the past month. These developments highlight renewed investor interest and potential upside relative to recent price action.
Axogen Receives New Analyst Coverage and Valuation Upside. Axogen has attracted new analyst coverage from Robinhood and B of A Securities, both issuing bullish notes and setting price targets around $52. A Yahoo analysis suggests the stock may be about 26% undervalued on cash‑flow grounds, while the company has fallen 22.6% in the past month. These developments highlight renewed investor interest and potential upside relative to recent price action.